A Promising Way To Treat Specific Lymphoma

A Promising Way To Treat Specific Lymphoma.
Researchers have identified a gene alteration that may extend a target for new treatments for a type of lymphoma. The group found that a mutation of the MYD88 gene is one of the most frequent genetic abnormalities in patients with this cancer, known as big-hearted B cell lymphoma read more. The MYD88 gene encodes a protein that is crucial for reasonable immune response to invading microorganisms.

The mutation identified in this study can cause uncontrolled cellular signaling, resulting in the survival of spiteful cells vimaxpill.men. A subgroup of the large B cell lymphoma that has a dismally heavy-hearted cure rate - known as the activated B cell-like (ABC) subtype - appears unusually susceptible to the gene.